Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses
Research and development	$ 26,868	$ 40,410
General and administrative	7,165	3,746
Total operating expenses	34,033	44,156
Operating loss	(34,033)	(44,156)
Other income	3,116
Income tax provision	0	(2,311)
Net loss	(30,917)	(46,467)
Other comprehensive loss:
Unrealized loss on marketable securities	(74)
Other comprehensive loss	(74)
Comprehensive loss	$ (30,991)	$ (46,467)
Net loss per ordinary share - basic	$ (1.84)	$ (2.78)
Net loss per ordinary share - diluted	$ (1.84)	$ (2.78)
Weighted average ordinary shares outstanding - basic	16,793,657	16,689,740
Weighted average ordinary shares outstanding - diluted	16,793,657	16,689,740